Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Study Finds Economic Benefits for 64-Slice CT, SPECT

By MedImaging staff writers
Posted on 29 Apr 2008
A multicenter study has found the cost-savings of the two major noninvasive methods for detecting coronary artery disease (CAD) varies based on the patient's heart history. More...


The study, performed by researchers from New York Presbyterian/Weill Cornell (New York, NY, USA), revealed that patients who underwent coronary computed tomographic angiography (CCTA), without a prior diagnosis of CAD, incurred costs US$603 lower (per patient average) than those who underwent myocardial perfusion imaging (myocardial perfusion imaging [MPI] or single photon emission tomography [SPECT]). Both groups had equal clinical outcomes. However, patients with known CAD who underwent MPI incurred healthcare costs $2451 lower (per patient average) than costs incurred by CCTA patients with equal clinical outcomes. These results suggest that CCTA may be a cost-efficient alternative in patients without a prior CAD diagnosis.

New York Presbyterian/Weill Cornell Cardiologist Dr. James K. Min presented the study's findings April 2008 at the 57th annual meeting of the American College of Cardiology in Chicago, IL, USA. "These are exciting data,” said Dr. Min. "This provides an initial foundation to suggest that CCTA may be used as a cost-efficient alternative to nuclear stress testing for evaluation of patients with suspected coronary artery disease.”

Recently, the U.S. Centers for Medicare and Medicaid Services (CMS) assigned transaction codes (T-codes) for CT dedicated to coronary angiography. Looking at multicenter payer claims from five health plans with memberships of at least 10 million people, the study examined cost effectiveness for patients undergoing CCT under T-codes, compared to matched patients undergoing MPI testing. Researchers collected data for 142,535 patients who underwent CCT or MPI for nine months before and after the test. Pre-test cardiac risk was assessed by cardiac risk factors and medications. MPI patients were matched to CCT patients using 11 categories of demographic and risk states. Cost and clinical effectiveness were measured in both downstream CAD costs and clinical events including myocardial infarction (MI), angina, and CAD-related hospitalization.


Related Links:
New York Presbyterian/Weill Cornell

Pocket Fetal Doppler
CONTEC10C/CL
New
Radiology Monitor
Barco MDNC-12130 Nio Fusion 12MP Radiology Monitor
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.